SecBot SecBot
6-K ·Filed Aug 21, 2026

CXXIF

C21 Investments Inc.
BEARISH
Impact 5/10
Horizondays Processed2mo ago SEC0001062993-26-004543
Notable filing: 6-K
Actionable Insight ▼ Bearish

The standalone Q1 results are clearly bearish, but the imminent Vireo acquisition (expected to close imminently) means the stock price will track the deal terms, not the underlying operational weakness. Traders should monitor for the final court order and regulatory approvals to ensure the deal closes as scheduled on August 21, 2026.

DirectionBearish
Confidencehigh
Horizondays

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

C21 Investments filed Q1 FY2027 results showing a significant operational deterioration: revenue fell 10.8% YoY to $7.6M, operating income swung from a $0.2M profit to a $1.2M loss, and net loss widened to $2.0M from $0.8M. The Nevada cannabis market is experiencing price compression and increased competition, with state-wide sales down over 12%. However, the company is in the process of being acquired by Vireo Growth Inc., with shareholder approval already obtained and closing expected on or about August 21, 2026, which largely mutes the standalone impact of these weak results for current shareholders.

Key Facts

  • Revenue declined 10.8% YoY to $7.6M from $8.6M.
  • Operating income swung to a loss of $1.2M from a profit of $0.2M.
  • Net loss widened to $2.0M from $0.8M.
  • Gross profit margin compressed to 32.5% from 34.9% YoY.
  • Cash from operations improved to $0.8M from $0.5M.
  • The Vireo acquisition (0.023052 Vireo shares per C21 share) is expected to close on or about August 21, 2026, after receiving 96.58% shareholder approval.

Financial Impact

Revenue down $0.9M YoY; operating income swing of -$1.4M; net loss increase of $1.2M.

revenueoperating incomenet lossgross margin

Risk Factors

  • Acquisition by Vireo may fail to close if regulatory or court approvals are not obtained.
  • Continued price compression and competition in the Nevada cannabis market could further erode margins.
  • The company carries a large uncertain tax position of $14.1M related to Section 280E.

Market Snapshot

Exchange
OTC
Sector
Medicinal Chemicals & Botanical Products

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001062993-26-004543
Exhibit: exhibit99-2.htm0001062993-26-004543
Exhibit: exhibit99-4.htm0001062993-26-004543
Exhibit: exhibit99-3.htm0001062993-26-004543
Document: form6k.htm0001062993-26-004543
Document: 0001062993-26-004543-index-headers.html0001062993-26-004543
Document: 0001062993-26-004543-index.html0001062993-26-004543
Document: 0001062993-26-004543.txt0001062993-26-004543

Track record

4 reports on CXXIF

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Aug 21, 202612w ago 6-K Bearish 5/10 Viewing Entry $0.2590 No price data
  2. Jun 15, 202622w ago 6-K Bullish 7/10 Entry $0.2490 to $0.2390 ▼ −4.02% −3.88% vs SPY
  3. Jun 12, 202622w ago 20-F Mixed 5/10 Entry $0.2700 to $0.2388 ▼ −11.56% −12.82% vs SPY
  4. Jun 12, 202622w ago 6-K Mixed 5/10 Entry $0.2700 to $0.2388 ▼ −11.56% −12.82% vs SPY
Showing 4 of 4

US Market Status

Market Closed · Opens in 5h 49m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 21, 2026